Moritz Bünemann

Title: Moritz Bünemann: Innovator in Biochemical Research

Introduction

Moritz Bünemann is a notable inventor based in Waldbüttelbrunn, Germany. He has made significant contributions to the field of biochemical research, particularly in the development of innovative methods and tools for the determination of cyclic adenosine monophosphate (cAMP) concentrations.

Latest Patents

Bünemann holds two patents that showcase his expertise. The first patent, titled "Means and methods for the determination of cAMP in vitro and in vivo," describes a chimeric peptide that includes a first detectable label, a cAMP binding moiety with a single binding site, and a second detectable label. This chimeric peptide is designed for the direct determination of cAMP concentration in both in vitro and in vivo settings. The patent also covers nucleic acids encoding the chimeric peptide, methods for its production and modification, and associated kits.

The second patent, "Millisecond activation switch for seven-transmembrane proteins," relates to a recombinant seven-transmembrane receptor. This invention features a receptor with the amino terminus on the extracellular side and the carboxy-terminus on the intracellular side of a membrane. It includes at least two detectable labels, with specific placements on the receptor. The patent further describes nucleic acid molecules encoding these receptors, as well as methods for identifying and screening compounds that can modify the biological functions of seven-transmembrane receptor proteins.

Career Highlights

Bünemann has worked at prestigious institutions, including Julius Maximilians University and Bayerische Julius-Maximilians-Universität Würzburg. His work has significantly advanced the understanding of receptor biology and the mechanisms of signal transduction.

Collaborations

Throughout his career, Bünemann has collaborated with esteemed colleagues such as Martin Lohse and Jean-Pierre Vilardaga. These collaborations have contributed to the development of innovative research methodologies and have enhanced the impact of his work in the scientific community.

Conclusion

Moritz Bünemann is a distinguished inventor whose work in biochemical research has led to significant advancements in the understanding of cAMP and seven-transmembrane proteins. His patents reflect a commitment to innovation and a deep understanding of complex biological systems.